Company Overview

Koios Medical is a healthcare technology company that specializes in AI-powered software for diagnosing cancer. Their SmartUltrasound platform uses artificial intelligence to assist physicians in accurately detecting and diagnosing breast and thyroid cancer. The software has been proven to be super-humanly accurate, is billable, and has received FDA clearance and CE Mark approval.

Business Model

• Subscription Model: Annual subscription pricing tailored to customer size.
• Distribution Partners: Collaborating with industry leaders like GE Healthcare and Philips.
• Licensing Fees: Koios Medical receives licensing fees from SmartUltrasound software installations.

Market Analysis

• Market Size: $1.6 billion annual market opportunity in the U.S. alone.
• Growth Drivers:
  • High demand for accurate cancer diagnosis.
  • Increasing adoption of AI in medical imaging.
  • Breast density notification laws increasing demand for supplemental ultrasounds.

Competitive Landscape

• Direct Competitors: Other AI-powered medical imaging solutions.
• Key Differentiators:
  • Super-human accuracy with Koios SmartUltrasound.
  • FDA and CE Mark approved.
  • Distribution network with major healthcare companies.

Growth Potential

• Market Penetration: Scaling globally through partnerships with healthcare leaders.
• Product Development: Expanding to other imaging modalities.
• Revenue Growth: Aiming to reach cashflow neutrality by the end of 2025.

Risks and Challenges

• Regulatory Compliance: Adhering to FDA and international regulatory standards.
• Market Penetration: Convincing healthcare providers to adopt new technology.
• Competition: Emerging competitors in AI-driven radiology.

Conclusion

Koios Medical is poised for significant growth by leveraging AI to transform cancer diagnosis. With strong strategic partners and a proven technology platform, it aims to capture a significant share of the burgeoning medical imaging AI market.

For more details, visit their Wefunder page​ (Wefunder)​.